Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Mantle-Cell × Spinal Puncture × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Meningeal Carcinomatosis 2 Lung Neoplasms 2 Leukemia, Biphenotypic, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Hairy Cell 1 Hematopoietic and Lymphatic System Neoplasm 1 Glioma 1 Glioblastoma 1 Germinoma 1 Diabetes Insipidus 1 Astrocytoma 1

Interventions

Rituximab 106 Cyclophosphamide 94 fludarabine phosphate 44 Peripheral Blood Stem Cell Transplantation 43 Cytarabine 42 Etoposide 38 Mycophenolic Acid 36 Filgrastim 35 Whole-Body Irradiation 34 Bortezomib 31 Tacrolimus 29 Methotrexate 29 Cyclosporine 29 Radiotherapy 28 Melphalan 28 Vincristine 26 Busulfan 26 Doxorubicin 25 Dexamethasone 25 Bendamustine Hydrochloride 22 Antilymphocyte Serum 22 Lenalidomide 21 Carmustine 21 ibrutinib 20 Granulocyte Colony-Stimulating Factor 17 fludarabine 16 zanubrutinib 15 venetoclax 15 obinutuzumab 15 acalabrutinib 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05910801 2024-11-18

V-MIND

Academic and Community Cancer Research United

Phase 2 Recruiting

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡